A study on quantitative electroencephalography of Alzheimer's disease patients in combination with donepezil and memantine and each single administration

A study on quantitative electroencephalography of Alzheimer's disease patients in combination with donepezil and memantine and each single administration - A study on quantitative electroencephalography of Alzheimer's disease patients in combination with donepezil and memantine and each single administration

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027818

Enrollment

Registered

2017-06-19

Start date

2016-02-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: A patient diagnosed as having dementia due to Alzheimer's disease at DSM-5 and whose treatment necessitates the initiation of donepezil or memantine alone. Or a patient who has been administered one of each of donepezil or memantine, and another one is newly administered additionally.

Exclusion criteria

Exclusion criteria: 1.A case of complication of other dementia or psychiatric disorder. 2.Cases with significant physical complications.

Design outcomes

Primary

Measure	Time frame
Changes on the quantitative electroencephalography three months after donepezil or memantine administration.	—

Countries

Japan

Contacts

Public ContactTakahiro MORI

Kagawa University School of Medicine Department of Neuropsychiatry

tmori@med.kagawa-u.ac.jp087-891-2167

Outcome results